Carol Marion Maclean

Title: Carol Marion Maclean: Innovator in Estrogen-Related Treatments

Introduction

Carol Marion Maclean is a notable inventor based in Bathgate, GB. She has made significant contributions to the field of medicine, particularly in the treatment of estrogen-related diseases. Her innovative approach aims to improve patient outcomes and enhance the quality of life for those affected by these conditions.

Latest Patents

Maclean holds a patent for a composition designed to treat one or more estrogen-related diseases. This invention focuses on administering a therapeutically effective amount of a Gn RH antagonist to patients. The goal is to maintain endogenous serum estradiol levels between about 20 pg/ml and 60 pg/ml, preferably between 30 pg/ml and 50 pg/ml, over a treatment period of at least four weeks. This method is designed to prevent or reduce the likelihood of developing estrogen deficiency-related side effects without relying on 'add-back' therapy. The simplicity and effectiveness of this composition are expected to increase patient acceptance and compliance with therapy.

Career Highlights

Maclean is currently associated with Lifearc, where she continues to work on innovative solutions in the medical field. Her dedication to research and development has positioned her as a key figure in her area of expertise.

Collaborations

Maclean collaborates with her coworker, Finn Larsen, to further advance their research and development efforts. Their combined expertise contributes to the success of their projects and the impact of their innovations.

Conclusion

Carol Marion Maclean's work in developing treatments for estrogen-related diseases showcases her commitment to improving patient care. Her innovative patent reflects her dedication to advancing medical science and enhancing the lives of those affected by these conditions.